Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

The World Health Organization (WHO) yesterday released a roadmap to address rising resistance to treatments for HIV, ...

Dramatic international funding cuts have thrown the global HIV response into turmoil, the United Nations said Tuesday, ...

A new UNAIDS report reveals that major funding cuts have led to service disruptions for those living with HIV, contributing ...

Millions of people, particularly in African countries, have lost access to drug treatments, prevention and testing putting ...

New HIV infections among gay and bisexual men in the United States have fallen over the past few years, in part due to earlier and more widespread use of effective antiretroviral therapy, according to ...

GENEVA (Reuters) -People living with HIV have died due to service disruptions caused by major funding cuts, while millions of ...

Public health officials are urging residents across South Central Idaho to take precautions after new data revealed a sharp ...

Ang Pagyakap sa Linya” tells audiences that a big part of curbing the spread of the HIV is by embracing the realities of it, ...

Dr Samuels said reducing Nigeria’s dependence on foreign donors is critical and emphasised APIN’s determination ...